China County Closes 82 Unlicensed Makers Of Drug Capsules, 10 Detained
This article was originally published in PharmAsia News
A county in China said it has closed 82 makers of drug capsules because they lacked licenses, and ordered seven with licenses to suspend operations until their raw materials and finished products could be examined.
You may also be interested in...
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.
Just as the MDR and IVDR are being implemented, increasing regulatory divergence in Europe is a growing danger to patient safety throughout the EU, not least through increasing costs and impacting device availability.
It’s time to focus on how the diagnostics sector will comply with the EU’s IVD Regulation. TÜV SÜD expert, Andreas Stange, explains why the IVD industry could be in trouble and what must be done now.